tiprankstipranks
Innoviva (INVA)
NASDAQ:INVA
US Market
INVA
Innoviva
RESEARCH TOOLSreports
Want to see INVA full AI Analyst Report?

Innoviva (INVA) Stock Forecast & Price Target

378 Followers
See the Price Targets and Ratings of:

INVA Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
4 Buy
0 Hold
1 Sell
Based on 5 analysts giving stock ratings to
Innoviva
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

INVA Stock 12 Month Forecast

Average Price Target

$34.60
▲(42.74% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Innoviva in the last 3 months. The average price target is $34.60 with a high forecast of $46.00 and a low forecast of $18.00. The average price target represents a 42.74% change from the last price of $24.24.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"17":"$17","32":"$32","47":"$47","24.5":"$24.5","39.5":"$39.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":46,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$46.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$34.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$18.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[17,24.5,32,39.5,47],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.11,24.87076923076923,26.63153846153846,28.392307692307693,30.153076923076924,31.91384615384615,33.674615384615386,35.43538461538461,37.19615384615385,38.956923076923076,40.7176923076923,42.47846153846154,44.23923076923077,{"y":46,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.11,23.993846153846153,24.877692307692307,25.76153846153846,26.645384615384614,27.529230769230768,28.413076923076922,29.29692307692308,30.18076923076923,31.064615384615387,31.948461538461537,32.832307692307694,33.716153846153844,{"y":34.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.11,22.716923076923077,22.323846153846155,21.93076923076923,21.537692307692307,21.144615384615385,20.751538461538463,20.358461538461537,19.965384615384615,19.572307692307692,19.17923076923077,18.786153846153844,18.393076923076922,{"y":18,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.65,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.14,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.79,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.63,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.17,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.16,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.99,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.98,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.83,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.41,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.11,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$46.00Average Price Target$34.60Lowest Price Target$18.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on INVA
Julian Harrison
BTIG
BTIG
$35→$42
Buy
73.27%
Upside
Reiterated
05/07/26
Innoviva (INVA) Receives a Rating Update from a Top Analyst
Goldman Sachs Analyst forecast on INVA
Asad Haider
Goldman Sachs
Goldman Sachs
$18
Sell
-25.74%
Downside
Reiterated
05/06/26
Goldman Sachs Sticks to Their Sell Rating for Innoviva (INVA)
Cantor Fitzgerald Analyst forecast on INVA
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$32
Buy
32.01%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Nuvalent (NASDAQ: NUVL) and Innoviva (NASDAQ: INVA)
H.C. Wainwright Analyst forecast on INVA
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$45→$46
Buy
89.77%
Upside
Reiterated
03/02/26
Analysts Offer Insights on Healthcare Companies: Cybin (NASDAQ: HELP), Twist Bioscience (NASDAQ: TWST) and Innoviva (NASDAQ: INVA)
Oppenheimer Analyst forecast on INVA
Trevor Allred
Oppenheimer
Oppenheimer
$35
Buy
44.39%
Upside
Downgraded
02/26/26
Analysts Are Neutral on These Healthcare Stocks: Innoviva (INVA), Arvinas Holding Company (ARVN)
Scotiabank Analyst forecast on INVA
Louise Chen
Scotiabank
Scotiabank
$55
Buy
126.90%
Upside
Reiterated
08/07/25
Scotiabank Reaffirms Their Buy Rating on Innoviva (INVA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG Analyst forecast on INVA
Julian Harrison
BTIG
BTIG
$35→$42
Buy
73.27%
Upside
Reiterated
05/07/26
Innoviva (INVA) Receives a Rating Update from a Top Analyst
Goldman Sachs Analyst forecast on INVA
Asad Haider
Goldman Sachs
Goldman Sachs
$18
Sell
-25.74%
Downside
Reiterated
05/06/26
Goldman Sachs Sticks to Their Sell Rating for Innoviva (INVA)
Cantor Fitzgerald Analyst forecast on INVA
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$32
Buy
32.01%
Upside
Reiterated
04/07/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Nuvalent (NASDAQ: NUVL) and Innoviva (NASDAQ: INVA)
H.C. Wainwright Analyst forecast on INVA
Ram Selvaraju
H.C. Wainwright
H.C. Wainwright
$45→$46
Buy
89.77%
Upside
Reiterated
03/02/26
Analysts Offer Insights on Healthcare Companies: Cybin (NASDAQ: HELP), Twist Bioscience (NASDAQ: TWST) and Innoviva (NASDAQ: INVA)
Oppenheimer Analyst forecast on INVA
Trevor Allred
Oppenheimer
Oppenheimer
$35
Buy
44.39%
Upside
Downgraded
02/26/26
Analysts Are Neutral on These Healthcare Stocks: Innoviva (INVA), Arvinas Holding Company (ARVN)
Scotiabank Analyst forecast on INVA
Louise Chen
Scotiabank
Scotiabank
$55
Buy
126.90%
Upside
Reiterated
08/07/25
Scotiabank Reaffirms Their Buy Rating on Innoviva (INVA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Innoviva

3 Months
Louise ChenScotiabank
Success Rate
2/3 ratings generated profit
67%
Average Return
+11.37%
Copying Louise Chen's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +11.37% per trade.
1 Year
Louise ChenScotiabank
Success Rate
3/3 ratings generated profit
100%
Average Return
+22.30%
Copying Louise Chen's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.30% per trade.
2 Years
Louise ChenScotiabank
Success Rate
3/3 ratings generated profit
100%
Average Return
+20.57%
Copying Louise Chen's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +20.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

INVA Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
6
3
1
1
2
Buy
0
3
3
4
1
Hold
0
0
0
0
0
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
6
6
4
5
4
In the current month, INVA has received 3 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. INVA average Analyst price target in the past 3 months is 34.60.
Each month's total comprises the sum of three months' worth of ratings.

INVA Financial Forecast

INVA Earnings Forecast

Next quarter’s earnings estimate for INVA is $0.42 with a range of $0.07 to $0.60. The previous quarter’s EPS was $2.22. INVA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year INVA has Performed in-line its overall industry.
Next quarter’s earnings estimate for INVA is $0.42 with a range of $0.07 to $0.60. The previous quarter’s EPS was $2.22. INVA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year INVA has Performed in-line its overall industry.

INVA Sales Forecast

Next quarter’s sales forecast for INVA is $110.94M with a range of $106.79M to $113.92M. The previous quarter’s sales results were $101.45M. INVA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year INVA has Performed in-line its overall industry.
Next quarter’s sales forecast for INVA is $110.94M with a range of $106.79M to $113.92M. The previous quarter’s sales results were $101.45M. INVA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year INVA has Performed in-line its overall industry.

INVA Stock Forecast FAQ

What is INVA’s average 12-month price target, according to analysts?
Based on analyst ratings, Innoviva’s 12-month average price target is 34.60.
    What is INVA’s upside potential, based on the analysts’ average price target?
    Innoviva has 42.74% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is INVA a Buy, Sell or Hold?
          Innoviva has a consensus rating of Moderate Buy which is based on 4 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Innoviva’s price target?
            The average price target for Innoviva is 34.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $46.00 ,the lowest forecast is $18.00. The average price target represents 42.74% Increase from the current price of $24.24.
              What do analysts say about Innoviva?
              Innoviva’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of INVA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.